Swiss drugmaker Roche plans to complete its $4.3 billion takeover of gene therapy specialist Spark Therapeutics on Tuesday after U.S. and British authorities ruled the deal would not hurt competition in haemophilia A treatment.

Roche to complete $4.3 billion Spark deal as regulators give all clear

spark-therapeutics

Spark Therapeutics, News on Spark Therapeutics, stories on Spark Therapeutics, articles on Spark Therapeutics, Spark Therapeutics stories at Wion, Spark Therapeutics news, Spark Therapeutics latest news

spark therapeutics

Roche to complete $4.3 billion Spark deal as regulators give all clear